Ingredion (NYSE: INGR) insider transactions
In the twelve months to 10 November 2026, executives and directors of Ingredion reported 8 open-market sales of 50,348 shares ($6.0m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 15 October 2026 | Reynoso Diego | EVP & Chief Financial Officer | Grant or award | +5,396 | $97.27 | 5,396 | Form 4 |
| 15 October 2026 | Reynoso Diego | EVP & Chief Financial Officer | Grant or award | +7,264 | $97.27 | 12,660 | Form 4 |
| 5 August 2026 | Fischer David B | Director | Open-market sale | −1,662 | $102.31 | 19,930 | Form 4 |
| 1 July 2026 | Escoe T. Kenneth | Director | Grant or award | +1,516 | $98.97 | 1,516 | Form 4 |
| 20 May 2026 | Fischer David B | Director | Grant or award | +1,797 | $107.34 | 21,435 | Form 4 |
| 20 May 2026 | Jordan Rhonda L | Director | Grant or award | +1,797 | $107.34 | 28,909 | Form 4 |
| 20 May 2026 | Magro Charles V. | Director | Grant or award | +1,797 | $107.34 | 11,345 | Form 4 |
| 20 May 2026 | Reich Victoria | Director | Grant or award | +1,797 | $107.34 | 21,927 | Form 4 |
| 20 May 2026 | Suever Catherine A | Director | Grant or award | +1,797 | $107.34 | 8,710 | Form 4 |
| 20 May 2026 | Talbot Siobhan | Director | Grant or award | +1,797 | $107.34 | 1,797 | Form 4 |
| 20 May 2026 | Tanda Stephan B. | Director | Grant or award | +1,797 | $107.34 | 1,797 | Form 4 |
| 20 May 2026 | Uribe Jorge A. | Director | Grant or award | +1,797 | $107.34 | 14,815 | Form 4 |
| 20 May 2026 | Verduin Patricia | Director | Grant or award | +1,797 | $107.34 | 5,620 | Form 4 |
| 20 May 2026 | Wilson Dwayne Andree | Director | Grant or award | +1,797 | $107.34 | 30,536 | Form 4 |
| 2 May 2026 | Ritchie Robert A. | EVP, Food & Industrial Ingred. | Shares withheld for tax | −842 | $110.43 | 31,178 | Form 4 |
| 16 April 2026 | Tanda Stephan B. | Director | Gift | −380 | — | 0 | Form 4 |
| 16 April 2026 | Tanda Stephan B. | Director | Gift | +380 | — | 10,737 | Form 4 |
| 15 April 2026 | Uribe Jorge A. | Director | Gift | −312 | — | 12,925 | Form 4 |
| 15 April 2026 | Uribe Jorge A. | Director | Gift | +312 | — | 6,449 | Form 4 |
| 9 April 2026 | Tanda Stephan B. | Director | Gift | −1,557 | — | 380 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Ingredion page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.